00000000nam 2200000zi 4500
0019.558260
003CaOODSP
00520210716115406
007cr |||||||||||
008150406s2002    xxc|||||o    f|0| 0 eng d
020 |a0662329627
040 |aCaOODSP|beng
043 |an-cn---
0861 |aCP32-79/37-2002E-PDF|zCP32-79/37-2002E-IN
1001 |aLehoux, Pascale,|d1967- |eauthor.
24510|aCould new regulatory mechanisms be designed after a critical assessment of the value of health innovations? / |cby Pascale Lehoux.
264 1|aSaskatoon, Saskatchewan : |bPrivy Council, |c2002.
300 |a1 online resource (viii, 29 pages) : |bfigures, tables.
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aDiscussion paper ; |vNo. 37
590 |a03-06|b2003-02-07
69007|aCosts|2gcpds
69007|aHealth care system|2gcpds
69007|aTechnology|2gcpds
7101 |aCommission on the Future of Health Care in Canada, |eissuing body.
77508|tUne analyse critique de la valeur des technologies et des processus innovants peut-elle nous amener à concevoir de nouveaux instruments de régulation? / |w(CaOODSP)9.591162
830#0|aDiscussion paper (Commission on the Future of Health Care in Canada)|vNo. 37|w(CaOODSP)9.504497
85640|ahttp://publications.gc.ca|qPDF|s1414 KB|uhttps://publications.gc.ca/collections/Collection/CP32-79-37-2002E.pdf|yNo. 37